文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

重症脓毒症患者的补体激活:与炎症及疾病严重程度无关

Complement activation in severely ill patients with sepsis: no relationship with inflammation and disease severity.
PubMed 文献 · Crit Care · 2023-02-16
一句话结论重症脓毒症或脓毒性休克患者补体系统已深度激活,但与炎症标志物、SOFA评分、休克发生率及死亡率均无显著关联。

本研究为前瞻性研究二次分析,纳入209例住院脓毒症患者(多数伴休克),在诊断后24小时内采集EDTA血浆,用酶联免疫吸附试验检测C3、C3a、C3c、C5、C5a及可溶性终末补体复合物浓度。结果显示重症患者补体因子浓度较健康对照显著升高(均P < 0.01),提示补体系统深度激活;各补体因子之间相关一致,但与白细胞数、C反应蛋白、铁蛋白浓度及单核细胞HLA-DR表达等炎症标志物无显著相关。补体因子浓度与SOFA评分、脓毒性休克发生率及死亡率均无关联(均P > 0.05)。作者认为,感染进展为重症脓毒症或脓毒性休克时补体通路已深度激活,不再与失调的炎症反应或临床结局相关,对临床结局不再有预测价值。

要点

  • 209例住院脓毒症患者(多数伴休克)诊断后24小时内血浆C3、C3a、C3c、C5、C5a及可溶性终末补体复合物均较健康对照显著升高(均P < 0.01),提示补体系统深度激活。
  • 各补体因子之间相关一致,但与白细胞数、C反应蛋白、铁蛋白浓度及单核细胞HLA-DR表达均无显著相关。
  • 补体因子浓度与SOFA评分、脓毒性休克发生率及死亡率均无显著关联(均P > 0.05)。
  • 作者认为,在重症脓毒症或脓毒性休克患者中补体系统激活程度已不再对临床结局有预测价值。

适用人群与场景

  • 209例住院脓毒症患者,多数表现为休克;血浆样本于脓毒症诊断后24小时内采集。

研究设计与关键结果

  • 研究类型:前瞻性研究的二次分析;样本量209例住院脓毒症患者,多数伴休克。
  • 检测方法:于脓毒症诊断后24小时内采集乙二胺四乙酸(EDTA)血浆,用酶联免疫吸附试验测定补体因子C3、C3a、C3c、C5、C5a及可溶性终末补体复合物浓度。
  • 主要结果:重症脓毒症患者血浆补体因子浓度提示补体系统深度激活,所有补体因子与健康对照相比均P < 0.01。
  • 相关性分析:Spearman秩相关检验显示各补体因子之间关系一致,但补体因子与白细胞数、C反应蛋白、铁蛋白浓度及单核细胞HLA-DR表达等炎症标志物之间无显著相关。
  • 临床结局:补体因子浓度与序贯器官衰竭评估(SOFA)评分、脓毒性休克发生率及死亡率均无关联(均P > 0.05)。

证据类型、等级与局限

  • 证据类型:前瞻性研究的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,感染一旦进展为重症脓毒症或脓毒性休克,补体通路已深度激活,不再与失调的炎症反应相关,也不再与临床结局相关。
  • 作者认为,在该重症患者群体中补体系统激活程度已不再对临床结局有预测价值。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Sepsis is characterized by a dysregulated immune response to infection. The complement system plays an important role in the host defence to pathogens. However, exaggerated complement activation might contribute to a hyperinflammatory state. The interplay between complement activation and inflammation in relationship with adverse outcomes in sepsis patients is unclear.

METHODS: Secondary analysis of complement factors in a prospective study in 209 hospitalized sepsis patients, of whom the majority presented with shock. Concentrations of complement factors C3, C3a, C3c, C5, C5a, and soluble terminal complement complex were assessed in ethylenediaminetetraacetic acid plasma samples collected within 24 h after sepsis diagnosis using enzyme-linked immunosorbent assays.

RESULTS: The concentration of complement factors in plasma of severely ill sepsis patients indicated profound activation of the complement system (all P < 0.01 compared to healthy controls). Spearman rank correlation tests indicated consistent relationships between the different complement factors measured, but no significant correlations were observed between the complement factors and other inflammatory biomarkers such as leukocyte numbers, C-reactive protein and ferritin concentrations, or HLA-DR expression on monocytes. The concentration of complement factors was not associated with Sequential Organ Failure Assessment score, the incidence of septic shock, and mortality rates (all P > 0.05) in this cohort of patients with high disease severity.

CONCLUSIONS: Once an infection progresses to severe sepsis or septic shock, the complement pathway is already profoundly activated and is no longer related to a dysregulated inflammatory response, nor to clinical outcome. This implies that in this patient category with severe disease, the complement system is activated to such an extent that it no longer has predictive value for clinical outcome.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. de Nooijer AH, Kotsaki A, Kranidioti E, et al. Complement activation in severely ill patients with sepsis: no relationship with inflammation and disease severity. Crit Care. 2023. PMID: 36797757. doi:10.1186/s13054-023-04344-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。